The prevalence of anxiety and depressive disorders in patients with diabetes
1 Endocrinology Diabetes and Metabolic Diseases, Department of CHU Souss Massa/ Faculty of Medicine and Pharmacy Ibn Zohr Agadir Morocco.
2 Endocrinology, Diabetes and Metabolic Diseases, Department of Military Hospital Avicenne Marrakech.
3 Biosciences and Health Research Laboratory, Faculty of Medicine and Pharmacy - CADI AYYAD University Marrakech.
4 Psychiatry Department, Military Hospital Avicenne Marrakech.
Research Article
World Journal of Advanced Research and Reviews, 2023, 18(03), 1091–1097
Article DOI: 10.30574/wjarr.2023.18.3.1067
Publication history:
Received on 09 May 2023; revised on 19 June 2023; accepted on 21 June 2023
Abstract:
Introduction: Diabetes is a common chronic metabolic pathology that affects 7.3% of Moroccans. Many epidemiological studies have shown that diabetes and anxiety-depressive disorders are associated in a non-random way and complicate each other.
Materials and methods: We conducted a cross-sectional study to the prevalence of depressive episode and anxiety in diabetic patients, and to trace their sociodemographic and medical profile. The study included 130 patients from the diabetes endocrinology department and the diabetes consultation of the Avicenna Military Hospital of Marrakech. The scale used was the HADS (Hospital Anxiety and Depression Scale) in its Arabic version. Sociodemographic and diabetes characteristics were collected by hetero-questionary.
Results: The average age of our patients was 50.5 years, 52% were female. The prevalence of depressive disorder was 43% and that of anxiety disorder 50%. Data analysis showed some significant results by highlighting the factors associated with anxiety and depressive disorders: Factors related to sociodemographic characteristics (age and gender), socioeconomic characteristics (professional activity) and medical characteristics (Comorbidities, toxic antecedents and family antecedents of diabetes) characteristics related to the pathology itself (type and age of diabetes, its acute and chronic complications and the therapeutic regime).
Conclusion: The research and treatment of anxiety-depressive disorders in diabetic patients should be systematic in order to improve the management and prognosis of diabetes.
Keywords:
Diabetes; Anxiety; Depression; HADS
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0